Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell-Reference-Cited by-同舟云学术

Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell

Published:2009-03 Issue:3 Volume:126 Page:423-435
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:

Author:

Linn Yeh C.,Lau Siew Kee J.,Liu Bee H.,Ng Lee H.,Yong Hao X.,Hui Kam M.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2567.2008.02910.x/fullpdf

Reference34 articles.

1. Sensitivity of multidrug-resistant tumour cell lines to immunologic effector cells;Schmidt-Wolf;Cell Immunol,1996

2. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency;Lu;J Immunol,1994

3. Generation of cytokine-induced killer cells from leukemic samples with in vitro cytotoxicity against autologous and allogeneic leukemic blasts;Linn;Br J Hematol,2002

4. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumour cell activity;Schmidt-Wolf;J Exp Med,1991

5. Expansion of Philadelphia chromosome-negative CD3+CD56+ cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice;Hoyle;Blood,1998

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokine-induced killer cells: new insights for therapy of hematologic malignancies;Stem Cell Research & Therapy;2024-08-13

2. Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy;Cell Reports Methods;2024-08

3. The antitumor effect of extracellular vesicles derived from cytokine-activated CD8+ T cells;Journal of Leukocyte Biology;2024-05-16

4. Nanotechnology as an emerging option in cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024

5. How can Cytokine-induced killer cells overcome CAR-T cell limits;Frontiers in Immunology;2023-08-22